Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis

• প্রধান লেখক: Yanru Wang (লেখক), Xiaojie Jin (লেখক), Qin Fan (লেখক), Chenghao Li (লেখক), Min Zhang (লেখক), Yongfeng Wang (লেখক), Qingfeng Wu (লেখক), Jiawei Li (লেখক), Xiuzhu Liu (লেখক), Siyu Wang (লেখক), Yu Wang (লেখক), Ling Li (লেখক), Jia Ling (লেখক), Chaoxin Li (লেখক), Qianqian Wang (লেখক), Yongqi Liu (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

The Huashi Baidu Formula (HSBDF), a key Chinese medical drug, has a remarkable clinical efficacy in treating acute lung injury (ALI), and it has been officially approved by the National Medical Products Administration of China for drug clinical trials. Nevertheless, the regulated mechanisms of HSBDF...